Provided by Tiger Trade Technology Pte. Ltd.

Aptorum Group Ltd

5.07
-0.7700-13.18%
Post-market: 4.94-0.1300-2.56%19:37 EDT
Volume:47.31K
Turnover:256.59K
Market Cap:4.13M
PE:-1.77
High:5.82
Open:5.82
Low:5.05
Close:5.84
52wk High:25.90
52wk Low:5.05
Shares:814.38K
Float Shares:529.90K
Volume Ratio:0.77
T/O Rate:8.93%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8593
EPS(LYR):-1.8543
ROE:-17.05%
ROA:-10.04%
PB:0.19
PE(LYR):-2.73

Loading ...

Niki BioSolutions Accelerates Its Alzheimer’s Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics

GlobeNewswire
·
Sep 14

Aptorum’s Niki BioSolutions to Present at H.C. Wainwright Global Investment Conference

Reuters
·
Sep 08

Aptorum Names Ian Huen CEO in Post-Merger Management Change

Reuters
·
Sep 05

Aptorum Group Ltd trading resumes

TIPRANKS
·
Sep 04

NASDAQ Trade Halt Volatility Trading Pause at 10:19 Am

Reuters
·
Sep 04

Niki BioSolutions files $75M mixed securities shelf

TIPRANKS
·
Aug 28

Aptorum Files Amended 8-K Updating DiamiR Biosciences Financial Statements

Reuters
·
Aug 22

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

Aptorum FY26 H1 Net Loss Widens to $1.31 Million; Operating Cash Outflow Rises to $1.55 Million

Reuters
·
Aug 22

Niki Biosolutions - Financial Terms of Agreement not Disclosed

THOMSON REUTERS
·
Jul 23

Niki Biosolutions Enters into Strategic Agreement to Provide Apoe Testing Services for Progressive Medical Research (pmr)

THOMSON REUTERS
·
Jul 23

NASDAQ Trade Halt Volatility Trading Pause at 03:51 Pm

Reuters
·
Jul 21

Aptorum Group Ltd trading halted, news pending

TIPRANKS
·
Jul 18

Aptorum to Implement 1-for-10 Reverse Stock Split

MT Newswires Live
·
Jul 16

Aptorum provide update on DiamiR merger, announces 1-for-10 reverse stock split

TIPRANKS
·
Jul 16

Aptorum Group - Niki Biosolutions to Trade on NASDAQ Under Ticker Niki

THOMSON REUTERS
·
Jul 16

Press Release: Aptorum Group Provides Update on Diamir Biosciences Merger

Dow Jones
·
Jul 16

Q1 trading statement for the three months ended 30 June 2026

GlobeNewswire
·
Jul 15